[Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
Alegre
M
M
Noé
E
E
Martínez Lage
J M
JM
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use*; D004347:Drug Interactions; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D011605:Psychoses, Substance-Induced / Q000209:etiology*
D000900:Anti-Bacterial Agents; D000978:Antiparkinson Agents; D001971:Bromocriptine; D004917:Erythromycin
Psicosis por interacción de eritromicina con bromocriptina en enfermedad de Parkinson.